CCDC144NL inbitor LY294002, an inhibitor of PI3K, can impact the phosphatidylinositol signaling pathways, which are instrumental in various cellular processes including those that could regulate proteins like CCDC144NL. Rapamycin, by inhibiting mTOR, can lead to changes in protein synthesis pathways, which would in turn influence the synthesis and possibly the abundance of CCDC144NL in the cell. SB203580 and U0126 target the p38 MAPK and MEK1/2, respectively, both of which are components of the MAPK/ERK signaling pathway that regulates gene expression and cellular response to stress, potentially affecting the expression levels of CCDC144NL.
The JNK pathway, modulated by SP600125, plays a role in cellular stress response and apoptosis, which can influence the transcription or stability of CCDC144NL. Y-27632's inhibition of ROCK affects the organization of the actin cytoskeleton, which is crucial for maintaining cell shape and motility, processes that could be related to CCDC144NL's cellular function. PD98059, another MEK inhibitor, affects the ERK pathway and thus could modulate transcription factors that regulate the expression of CCDC144NL. XAV-939 and IWP-2 are known to influence the Wnt/β-catenin pathway, which is associated with gene expression and cellular development. By inhibiting components of this pathway, these compounds can affect the transcriptional activity of genes, potentially including CCDC144NL. Similarly, DAPT inhibits Notch signaling, which can lead to changes in the gene expression patterns within the cell, influencing the levels of CCDC144NL. Dasatinib, by inhibiting Src family kinases, and NSC23766, by inhibiting Rac1,can affect various signaling pathways that influence the regulation and activity of CCDC144NL. Src family kinases are involved in multiple signal transduction pathways that can control cell proliferation, differentiation, and survival, while Rac1 is a small GTPase that regulates the organization of the actin cytoskeleton and cell migration, which can have implications for proteins like CCDC144NL that may be involved in these cellular processes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, which can modulate phosphatidylinositol signaling affecting CCDC144NL associated pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, which can alter protein synthesis pathways, potentially affecting the synthesis of CCDC144NL. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAPK, which can influence stress response pathways that may regulate CCDC144NL expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which can alter signaling pathways that may control the transcription or stability of CCDC144NL. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Inhibits ROCK, influencing cytoskeletal organization and potentially CCDC144NL-related cellular processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, which can modulate the ERK pathway affecting transcription factors that regulate CCDC144NL. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $35.00 $115.00 $515.00 | 26 | |
Inhibits tankyrase, affecting β-catenin degradation and Wnt signaling pathways that may involve CCDC144NL. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $94.00 $286.00 | 27 | |
Inhibits Wnt production, which can decrease Wnt signaling and potentially the expression of CCDC144NL. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $99.00 $335.00 $836.00 $2099.00 | 47 | |
Inhibits Notch signaling, which can result in altered gene expression patterns including those of CCDC144NL. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Inhibits Src family kinases, potentially affecting signaling pathways that regulate CCDC144NL activity. | ||||||